OMV's Rally Faces Dividend Reset as Borouge Delay Unsettles Payout Formula

OMV shares surged 27% YTD but trade above €58 consensus; Q1 profit fell 12%, dividend policy overhauled, and BGI IPO delay halves 2026 cash flow expectations to $250M.

OMV shares have surged roughly 27% since the start of the year, yet the rally is running ahead of what the analyst community deems rational. The Austrian oil and gas group’s stock closed at €61.35 on Friday, well above the average price target of €58.00 derived from three May estimates. The target implies a discount of over 5%, even as the six-month rating trend remains firmly "buy".

The disconnect is most apparent in the spread between individual bank calls. UBS stands out with a target of €68.00, while the rest of the consensus sits further back. The stock has slipped about 2% in the past seven days, pulling back from a 52-week high of €63.85 hit earlier in the month. Technical indicators suggest the pullback is orderly: the share price still trades 1.48% above its 50-day moving average and 18.21% above the 200-day line, while the relative strength index at 40.7 signals no overheating.

What gives investors pause is a fundamental picture that has softened markedly. In the first quarter of 2026, OMV’s adjusted operating profit fell 12% to just under €1 billion. Net income dropped 22% to €323 million, and earnings per share landed at €0.99 — a 21% decline from a year earlier. Revenue from continuing operations shrank 6% to €5.855 billion, dragged down by the energy division where adjusted operating earnings plunged 21% to €723 million. Hydrocarbon production was off 7% at 288 kboe/d.

The chemicals business provided a rare bright spot. Adjusted operating profit in that segment jumped to €245 million, driven by the reclassification of Borealis, improved polyolefin margins and a stronger light-feedstock advantage. The fuels division held steady at €113 million, as higher refining margins were offset by hedging losses caused by disrupted crude flows. Net debt stood at €4.505 billion at quarter-end, with a leverage ratio of 17% — hardly a balance sheet worry.

But the real story shaping OMV’s outlook is the radical overhaul of its dividend policy and the Borouge Group International (BGI) listing delay that is already pinching expectations. At the end of May, the annual general meeting approved the payout for fiscal 2025 — a generous €4.40 per share (€3.15 regular, €1.25 special) to be distributed in June 2026. Yet it also set a new framework for future years.

Starting with the 2026 financial year, OMV will distribute 50% of the attributable dividends from BGI plus 20% to 30% of operating cash flow. The first payment under this formula is due in 2027. That makes BGI a direct lever on shareholder returns. The problem: OMV and its partner ADNOC have postponed the planned initial public offering of their joint venture until 2027, citing a need to strengthen the entity’s balance sheet in the current market environment.

The delay has already hit cash flow assumptions. OMV now expects to receive $250 million from BGI in 2026, half the $500 million previously forecast. The company estimates the shortfall will reduce its own dividend by €0.60 to €0.70 per share — a tangible hit for income-focused investors. The new payout architecture means any wobble in BGI’s cash generation will feed through to dividends faster than under the old regime.

The AGM also reshuffled the supervisory board. Edith Hlawati and Patrick Lammers were re-elected with 91.6% and 94.5% of votes respectively, while Andreas Klauser and Ahmed El-Hoshy joined the panel with near-unanimous approval. Executive compensation was overhauled: annual bonuses will now be paid entirely in cash, and long-term share-based incentives will run through a separate multi-year programme. A change-of-control clause that would have triggered accelerated bonus payments was eliminated, part of a broader governance cleanup.

Strategically, BGI is more than a dividend story. OMV is bundling Borealis, Borouge and Nova Chemicals with ADNOC’s XRG unit to create the world’s fourth-largest polyolefins producer. OMV and XRG each hold 50%, shifting the group’s centre of gravity further into chemicals. For the current fiscal year, management expects Brent crude to average around $65 a barrel and plans organic capital expenditure of roughly €3.2 billion.

The share price may remain well supported near current levels, but the combination of a slowing energy business, a diluted dividend outlook and analyst targets stuck below the market price suggests the rally is not without risk. Whether the chemicals momentum can offset the energy segment’s decline and whether BGI delivers on its revised timeline will dominate the debate ahead of second-quarter results.